InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,430.40
(
0.14%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.57
(
-0.15%
)
Bitcoin
65,223.58
(
0.39%
)
Post# of 34624
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

pharmeng

Send PM Follow Ignore
Followers 1
Posts 61
Boards Moderated 0
Alias Born 12/29/2011

pharmeng

Re: None

Thursday, 04/07/2016 10:53:17 AM

Thursday, April 07, 2016 10:53:17 AM

Post# of 34624
From FierceBiotech

AZ and VentiRx team up for PDL1-oncology vax trial in ovarian cancer

Ovarian cancer has few treatments and suffers from poor diagnosis, although AZ already markets Lynparza, an ADP-ribose polymerase (PARP) inhibitor, that's licensed for ovarian cancer patients who have BRCA gene mutations identified through a genetic test. This combo trial is seeking to expand on this and treat more women who do not have the BRCA gene.

There are currently a number of pharma and biotechs also researching this area, including GamaMabs' immune-activating cancer candidate and Clovis Oncology's ($CLVS) rucaparib.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent MRKR News
More MRKR News
InvestorsHub NewsWire

North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM

VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM

Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM

Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM

ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM

Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM

Start posting your company's news
Only $200 per official company press release!